[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-336002-en":59,"doc-seo-336002-105":80},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":36,"preview_page_count":4},336002,962075006959,"Anda","https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","MMP-11 expression in early luminal breast cancer - associations with clinical, MRI, pathological characteristics, and disease-free survival","Early hormone-positive breast cancer generally has favorable outcomes, yet late recurrences require sustained follow-up. Many studies link MMP-11 expression to poor prognosis, but evidence in early-stage disease is limited. This retrospective analysis evaluates MMP-11 as an early prognostic marker by measuring immunohistochemical expression and relating it to clinical, breast MRI, and pathological features and to disease-free survival.","Molière etal. BMC Cancer (2024) 24:295 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-11998-0](https://doi.org/10.1186/s12885-024-11998-0)  \nRESEARCH Open Access  \nMMP-11 expression in early luminal breast  cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival  \nSébastien Molière 1,2,3,4,5,6*, Massimo Lodi 1,2,3, Suzanne Leblanc7, Anne Gressel9, Carole Mathelin4,8,10, Fabien Alpy 1,2,3,4, Marie-Pierre Chenard4,9 and Catherine Tomasetto 1,2,3,4  \nAbstract  \nBackground Early hormone-positive breast cancers typically have favorable outcomes, yet long-term surveillance is crucial due to the risk of late recurrences. While many studies associate MMP-11 expression with poor prognosis in breast cancer, few focus on early-stage cases. This study explores MMP-11 as an early prognostic marker in hormonepositive breast cancers.  \nMethods In this retrospective study, 228 women with early hormone-positive invasive ductal carcinoma, treated surgically between 2011 and 2016, were included. MMP-11 expression was measured by immunohistochemistry, and its association with clinical and MRI data was analyzed.  \nResults Among the patients (aged 31–89, median 60, with average tumor size of 15.7 mm), MMP-11 staining was observed in half of the cases. This positivity correlated with higher uPA levels and tumor grade but not with nodal status or size. Furthermore, MMP-11 positivity showed specific associations with MRI features. Over a follow-up period of 6.5 years, only 12 oncological events occurred. Disease-free survival was linked to Ki67 and MMP-11 .  \nConclusion MMP-11, primarily present in tumor-surrounding stromal cells, correlates with tumor grade and uPA levels. MMP-11 immunohistochemical score demonstrates a suggestive trend in association with disease-free survival, independent of Ki67 and other traditional prognostic factors. This highlights the potential of MMP-11 as a valuable marker in managing early hormone-positive breast cancer.  \nKeywords Breast cancer, Microenvironment, MMP-11, Recurrence, Immunohistochemistry, Breast MRI  \n*Correspondence:  \nSébastien Molière  \n[sebastien.moliere@chru-strasbourg.fr](sebastien.moliere@chru-strasbourg.fr)  \n1Institute of Genetics and Molecular and Cellular Biology, Ill kirch, France 2Centre National de la Recherche Scientifique, UMR 7104, Ill kirch, France 3Institut National de la Santé et de la Recherche Médicale, U1258, Ill kirch, France  \n4University of Strasbourg, Ill kirch, France  \n5Department of Radiology, Strasbourg University Hospital, Hôpital de Hautepierre, Strasbourg, France  \n6Breast and Thyroid Imaging Unit, ICANS, Strasbourg, France 7Groupe Rhénan de Pathologie, Schiltigheim, France  \n8Department of Senology, ICANS, Strasbourg, France  \n9Department of Pathology, Strasbourg University Hospital, Hôpital de Hautepierre, Avenue Molière, Strasbourg, France  \n10Department of Gynecology and Obstetrics, Strasbourg University Hospital, Hôpital de Hautepierre, Avenue Molière, Strasbourg, France  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://crea","cbCais4sPYYqxrZd","https://ap.wps.com/l/cbCais4sPYYqxrZd","pdf",3323500,16,"English","en",105,"# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the study’s main aim regarding MMP-11 in early luminal breast cancer?\",\"answer\":\"To evaluate whether MMP-11 can serve as an early prognostic marker in hormone-positive breast cancers by linking its expression to clinical, MRI, pathological features, and disease-free survival.\"},{\"question\":\"How was MMP-11 expression measured and what cohort was analyzed?\",\"answer\":\"MMP-11 expression was measured by immunohistochemistry in 228 women with early hormone-positive invasive ductal carcinoma treated surgically between 2011 and 2016.\"},{\"question\":\"Which clinical or MRI features were associated with MMP-11 positivity?\",\"answer\":\"MMP-11 positivity correlated with higher uPA levels and tumor grade, showed no correlation with nodal status or tumor size, and had specific associations with MRI features.\"}]","MMP-11 expression in early luminal breast cancer - associations with clinical, MRI, pathological characteristics, and disease-free survival | PDF",1790013113,{"code":4,"msg":81,"data":82},"ok",{"site_id":75,"language":74,"slug":83,"title":65,"keywords":84,"description":66,"schema_data":85,"social_meta":139,"head_meta":141,"extra_data":143,"updated_unix":144},"mmp-11-expression-in-early-luminal-breast-cancer-associations-with-clinical-mri-pathological-characteristics-and-disease-free-survival","",{"@graph":86,"@context":138},[87,101,121],{"@type":88,"itemListElement":89},"BreadcrumbList",[90,94,96,99],{"item":91,"name":92,"@type":93,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":95,"name":9,"@type":93,"position":14},"https://docshare.wps.com/document/",{"item":97,"name":40,"@type":93,"position":98},"https://docshare.wps.com/document/research-report/",3,{"item":100,"name":65,"@type":93,"position":19},"https://docshare.wps.com/document/mmp-11-expression-in-early-luminal-breast-cancer-associations-with-clinical-mri-pathological-characteristics-and-disease-free-survival/336002/",{"url":100,"name":65,"@type":102,"image":103,"author":108,"headline":65,"publisher":110,"fileFormat":113,"inLanguage":74,"description":66,"dateModified":114,"datePublished":115,"encodingFormat":113,"isAccessibleForFree":116,"interactionStatistic":117},"DigitalDocument",{"url":104,"@type":105,"width":106,"height":107},"https://docshare.wps.com/thumbnails/mmp-11-expression-in-early-luminal-breast-cancer-associations-with-clinical-mri-pathological-characteristics-and-disease-free-survival/336002.png","ImageObject",300,407,{"name":63,"@type":109},"Person",{"url":91,"name":111,"@type":112},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":118,"interactionType":119,"userInteractionCount":52},"InteractionCounter",{"@type":120},"ViewAction",{"@type":122,"mainEntity":123},"FAQPage",[124,130,134],{"name":125,"@type":126,"acceptedAnswer":127},"What was the study’s main aim regarding MMP-11 in early luminal breast cancer?","Question",{"text":128,"@type":129},"To evaluate whether MMP-11 can serve as an early prognostic marker in hormone-positive breast cancers by linking its expression to clinical, MRI, pathological features, and disease-free survival.","Answer",{"name":131,"@type":126,"acceptedAnswer":132},"How was MMP-11 expression measured and what cohort was analyzed?",{"text":133,"@type":129},"MMP-11 expression was measured by immunohistochemistry in 228 women with early hormone-positive invasive ductal carcinoma treated surgically between 2011 and 2016.",{"name":135,"@type":126,"acceptedAnswer":136},"Which clinical or MRI features were associated with MMP-11 positivity?",{"text":137,"@type":129},"MMP-11 positivity correlated with higher uPA levels and tumor grade, showed no correlation with nodal status or tumor size, and had specific associations with MRI features.","https://schema.org",{"og:url":100,"og:type":140,"og:title":65,"og:site_name":111,"og:description":66},"article",{"robots":142,"canonical":100},"index,follow",{"doc_id":61,"site_id":75},1790197710]